Radiodermatitis
Conditions
Interventions
Experimental group: A group of 53 women with breast cancer will receive topical application of the moisturizing formulation with chamomile microparticles once a day after radiotherapy throughout the t
Sponsors
Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo
Hospital das Clinicas da Faculdade de Medicina de Ribeirão Preto
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 18 years older; confirmed diagnosis of breast cancer; indication of radiotherapy treatment; Not having started radiation therapy; non-history of allergic reactions to any other component of chamomile or lanolin; non-history of allergic reactions to fish, shrimp or seafood; Kanofsky greater than 70; No use of systemic corticosteroids. do not use heparin, oral anticoagulants and antiplatelet agents.
Exclusion criteria
Exclusion criteria: Present any injury at the treatment site; present skin involvement by the tumor;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find an increase in time for appearance of grade I radiodermatitis during radiotherapy, clinically evaluated by the RTOG scale of toxicity.;It is expected to find an improvement in skin-related quality of life during treatment, assessed using the Skin-index instrument.;It is expected to find a reduction in the number of patients with grade II, III and IV radiodermatitis during radiotherapy, clinically evaluated by the RTOG scale of toxicity. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected;Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactDanielle Garbuio
Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo
Outcome results
None listed